In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Akihiro Hirashiki
Speaker
Akihiro Hirashiki
Akihiro Hirashiki Akihiro Hirashiki

National Center for Geriatrics and Gerontology, Obu (Japan)

Specialities : Chronic Heart Failure , e-Cardiology, Rehabilitation and Sports Cardiology

8 presentations from this speaker

Cardiopulmonary exercise testing for assessing frailty status in stable elderly patients with heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : A Hirashiki (Obu,JP)

Exercise capacity is negatively associated with cerebral white matter hyperintensity in elderly patients with heart failure

Event : Heart Failure 2019

  • Session : Moderated Poster Session - Non pharmacological approach to heart failure world
  • Speaker : A Hirashiki (Obu,JP)

Use of composite laboratory measurements to assess frailty in stable elderly patients with heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Diagnostic Methods
  • Speaker : A Hirashiki (Obu,JP)

Clinical safety and usefulness of cardiopulmonary exercise testing for pulmonary hypertension.

Event : ESC Congress 2013

  • Session : Exercise testing and training
  • Speaker : A Hirashiki (Obu,JP)

Prognostic value of pulmonary hypertension in ambulatory patients with non-ischemic left ventricular systolic dysfunction

Event : ESC Congress 2013

  • Session : Mechanisms of heart failure deterioration
  • Speaker : A Hirashiki (Obu,JP)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are